Drug absorption from nifedipine hydrophilic matrix extended-release (ER) tablet-comparison with an osmotic pump tablet and effect of food (Q51567975)

7 April 2018

title

Drug absorption from nifedipine hydrophilic matrix extended-release (ER) tablet-comparison with an osmotic pump tablet and effect of food (English)

1 reference

7 April 2018

1 reference

Abrahamsson B

1 reference

7 April 2018

Alpsten M

1 reference

7 April 2018

Bake B

1 reference

7 April 2018

Jonsson UE

1 reference

7 April 2018

Eriksson-Lepkowska M

1 reference

7 April 2018

Larsson A

1 reference

7 April 2018

language of work or name

English

0 references

publication date

1 March 1998

1 reference

7 April 2018

Journal of Controlled Release

published in

1 reference

7 April 2018

volume

1 reference

7 April 2018

issue

1 reference

7 April 2018

page(s)

301-310

1 reference

7 April 2018

The nifedipine gastrointestinal therapeutic system (GITS). Evaluation of pharmaceutical, pharmacokinetic and pharmacological properties

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2897%2900267-8

7 January 2021

Investigation of nifedipine absorption in different regions of the human gastrointestinal (GI) tract after simultaneous administration of 13C- and 12C-nifedipine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2897%2900267-8

7 January 2021

Rate of increase in the plasma concentration of nifedipine as a major determinant of its hemodynamic effects in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2897%2900267-8

7 January 2021

Sustained release nifedipine formulations. An appraisal of their current uses and prospective roles in the treatment of hypertension, ischaemic heart disease and peripheral vascular disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2897%2900267-8

7 January 2021

Nifedipine gastrointestinal therapeutic system

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2897%2900267-8

7 January 2021

Absorption, gastrointestinal transit, and tablet erosion of felodipine extended-release (ER) tablets

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2897%2900267-8

7 January 2021

Determination of felodipine in plasma by capillary gas chromatography with electron capture detection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2897%2900267-8

7 January 2021

Per cent absorbed time plots derived from blood level and/or urinary excretion data

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2897%2900267-8

7 January 2021

Nifedipine kinetics and bioavailability after single intravenous and oral doses in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2897%2900267-8

7 January 2021

Stereoisomers of calcium antagonists which differ markedly in their potencies as calcium blockers are equally effective in modulating drug transport by P-glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2897%2900267-8

7 January 2021

Influence of Food Intake on Presystemic Clearance of Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2897%2900267-8

7 January 2021

Effect of food ingestion on nifedipine absorption and haemodynamic response

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2897%2900267-8

7 January 2021

Effect of food on nifedipine pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2897%2900267-8

7 January 2021

Food and nifedipine pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2897%2900267-8

7 January 2021

Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2897%2900267-8

7 January 2021

Clinical pharmacokinetics of nifedipine gastrointestinal therapeutic system. A controlled-release formulation of nifedipine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2897%2900267-8

7 January 2021

Relationship between the rate of appearance of oxprenolol in the systemic circulation and the location of an oxprenolol Oros 16/260 drug delivery system within the gastrointestinal tract as determined by scintigraphy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2897%2900267-8

7 January 2021

10.1016/S0168-3659(97)00267-8

Identifiers

DOI

1 reference

7 April 2018

1 reference

7 April 2018